The journey of a novel test called Cytosponge-TFF3 from lab research to clinical implementation during Covid-19.
Professor Rebecca Fitzgerald, Professor of Cancer Prevention and Interim Director at the MRC Cancer Unit, University of Cambridge
Rebecca Fitzgerald is Professor of Cancer Prevention and Interim Director at the MRC Cancer Unit, University of Cambridge. She leads the Early Detection Programme of the CRUK Cambridge Centre which is part of the International Alliance in Early Detection (ACED) and practices medicine as Hon. Consultant in Gastroenterology and Oncology at Addenbrooke's Hospital. The focus of her research group is to investigate the steps in malignant transformation in the oesophagus and stomach and to use this information to improve clinical early detection strategies. Her work to develop and implement the Cytosponge and related biomarker assays for detection of Barrett's oesophagus and associated dysplasia has been awarded a number of prizes including the Westminster Medal, the BMJ Gastro team of the year, an NHS Innovation prize, the CRUK Jane Wardle Early Detection Prize and recently the Don Listwin prize. In 2013, she was elected as a Fellow of the Academy of Medical Sciences and in 2021 elected a Member of EMBO. Rebecca is committed to teaching and is a Fellow of Medical Sciences at Trinity College Cambridge.
The lecture will be preceded by a short presentation from a CSAR PhD Award Winner.
Benjamin Droguet, Department of Chemistry
Thank you for your interest in CSAR and its programme. If you would like to help us maintain our activities at their current level, you can make a donation to CSAR here, via PayPal or a bank card. Your gift will by default go into our general income fund; if you would like it to be used for a specific purpose such as the PhD Students Awards scheme, please let us know at email@example.com. CSAR is a registered charity run by volunteers.